Study in Patients With Tumours Requiring Arginine to Assess ADI-PEG 20 With Atezolizumab, Pemetrexed and Carboplatin
Clinical trial NCT03498222 · WITHDRAWN
Trial details
- NCT number
- NCT03498222
- Sponsor
- Queen Mary University of London
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-01
- Primary completion
- 2020-01-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.